We all need an understanding of patient advocacy group capabilities – we need to be real about our own capabilities too.” Jeanne Regnante, Executive Director, Head, Patient engagement strategy office, Office of the CPO, Merck & Co

Although patient advocacy and pharma have different starting points, they still share the common goal – to improve lives of people suffering from a particular condition. Despite this, many in pharma struggle to collaborate with these groups in a meaningful way.

That is why MK&A and eyeforpharma asked a range of global patient advocacy groups about their engagement with industry, academia, and the regulators to date and compiled it in our latest whitepaper: “Incorporating the Patient’s Voice: Analysis of The Global Patient Advocate Survey”

Fill in the form on the right to download the full survey results and analysis >>

This exclusive 22-page whitepaper also compiles expert commentary from the following leaders, on how to successfully engage with patient advocacy groups:
  • Jeff Sherman, CMO, Horizon Pharma
  • Jeanne Regnante, Executive Director, Head, Patient engagement strategy office, Office of
  • the CPO, Merck & Co, Inc
  • John Whyte, Director, Professional Affairs and Stakeholder Engagement, FDA
  • Jane Reese-Coulbourne, Senior Consultant, MK&A
Enter your details on the right to receive the full analysis >>

This whitepaper provides you with direct insights from patient advocacy groups including:
  • The barriers they are faced with for successful collaborations including funding, time and resources and how you can support them.
  • How successful engagements focus around communicating outcomes and how this builds trust and lasting relationships
  • Direction on how to develop guidelines on engagement with these groups including metrics and best practice advice.


eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions
Caitlin Champion
Global Project Director
eyeforpharma
+ 44 (0) 207 375 7190


Download the full analysis

Incorporating the Patient’s Voice: Analysis of The Global Patient Advocate Survey